Related Experiment Video
Updated: Jul 12, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
MTHFR C677T polymorphism and osteoporotic fractures
C Valero1, M A Alonso, M T Zarrabeitia
11Department of Internal Medicine, Hospital U. M. Valdecilla, University of Cantabria, Santander, Spain.
The C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is not linked to osteoporotic fractures. Further research is needed to explore potential associations in specific populations.
Area of Science:
- Genetics and Molecular Biology
- Bone Health and Osteoporosis Research
Background:
- The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) has been inconsistently linked to cardiovascular events and osteoporosis risk.
- Previous studies on the association between MTHFR C677T polymorphism and osteoporotic fractures have yielded controversial results.
Purpose of the Study:
- To investigate the relationship between the MTHFR C677T polymorphism and the risk of osteoporotic fractures using a case-control study design.
Main Methods:
- A case-control study was conducted involving 823 subjects, including 365 controls, 136 with vertebral fractures, and 322 with hip fractures.
- The MTHFR C677T polymorphism was genotyped using a Taqman assay.
- A meta-analysis was performed, combining the current study's data with previous published reports.
Main Results:
- The distribution of MTHFR genotypes did not differ significantly between fracture patients and control groups.
- Age-adjusted odds ratios (OR) for hip and vertebral fractures showed no significant association with the MTHFR TT genotype compared to TC/CC genotypes in both men and women.
- The meta-analysis confirmed a lack of association between MTHFR C677T polymorphism and vertebral (OR=1.1, p=0.65) or peripheral fractures (OR=1.2, p=0.45), although significant heterogeneity was noted.
Conclusions:
- The MTHFR C677T polymorphism does not appear to be associated with the overall risk of osteoporotic fractures.
- Significant heterogeneity in previous study results suggests the need for further investigations in specific population subgroups to clarify potential influences.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase